A Phase I, Randomized, Double-Blind Study to Assess the Effects of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of Repeat Oral Dosing of Casopitant in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Casopitant (Primary) ; Ketoconazole
- Indications Chemotherapy-induced nausea and vomiting; Postoperative nausea and vomiting; Seborrhoeic dermatitis
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 19 Sep 2007 Status changed from recruiting to completed.
- 27 Jun 2007 New trial record.